Xponential Fitness outlook hit by weaker sales, slower studio expansion

UBS cut its Xponential Fitness price target to $4.50 from $7 after weaker sales led management to reduce guidance. The company now expects FY2026 revenue of $250 million-$260 million and EBITDA of $91 million-$97 million, signaling a materially weaker operating outlook and likely pressure on the shares.